IDX — Integral Diagnostics Share News
0.000.00%
- AU$785.95m
- AU$1.34bn
- AU$788.74m
Brief: Integral Diagnostics H1 Net Loss AUD 0.4 Million
Citi resumes coverage on Australia's Integral Diagnostics with "neutral" rating
Brief: Integral Diagnostics Completes Merger With Capitol Health
Brief: Australia's ACCC Says Integral Diagnostics Acquisition Of Capitol Health Unopposed, Subject To Divestiture
Brief: Capitol Health Says Capitol Shareholders Vote In Favour Of Proposed Merger With Integral Diagnostics
Brief: Capitol Health Says IDX Engaging With ACCC
Brief: Integral Diagnostics Says It Is Engaging With ACCC On Potential Divestment Of Capitol's Clinic In Victoria
Brief: Integral Diagnostics Says Court Approves Convening Of Scheme Meeting
Brief: Integral Diagnostics Says ACCC Will Shortly Publish Market Inquiries Letter
Brief: Integral Diagnostics Achieved Mid-Teens Revenue Growth In July
Brief: Integral Diagnostics Says Merger Implementation Deed On Terms Consistent With Previously Agreed
Australia's Capitol Health soars on $272 mln takeover bid from Integral Diagnostics
Brief: Capitol Health Says Enters Into Process Deed Following Indicative Proposal From Integral Diagnostics
Brief: Integral Diagnostics Says Entered Into Merger Process Deed With Capitol Health Limited
Citi raises FY24 EBITDA forecast for Integral Diagnostics, hikes PT
Brief: Integral Diagnostics Sees FY24 Replacement And Growth Capex Between A$30.0M To A$40.0M.
Brief: Integral Diagnostics Says H1 Net Debt A$210 Mln
Australian healthcare firms to battle cost pressures, soft margins in 2024 - Morgan Stanley
Morgan Stanley cuts rating, PT on Australia's Integral Diagnostics